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Osteoclasts are essential for bone dynamics and calcium homeostasis. The cells form a tight seal on the bone surface, onto
which they secrete acid and proteases to resorb bone. The seal is associated with a ring of actin filaments. Cortactin, a c-Src
substrate known to promote Arp2/3-mediated actin assembly in vitro, is expressed in osteoclasts and localizes to the
sealing ring. To address the role of cortactin and actin assembly in osteoclasts, we depleted cortactin by RNA interference.
Cortactin-depleted osteoclasts displayed a complete loss of bone resorption with no formation of sealing zones. On
nonosteoid surfaces, osteoclasts flatten with a dynamic, actin-rich peripheral edge that contains podosomes, filopodia, and
lamellipodia. Cortactin depletion led to a specific loss of podosomes, revealing a tight spatial compartmentalization of
actin assembly. Podosome formation was restored in cortactin-depleted cells by expression of wild-type cortactin or a Src
homology 3 point mutant of cortactin. In contrast, expression of a cortactin mutant lacking tyrosine residues phosphor-
ylated by Src did not restore podosome formation. Cortactin was found to be an early component of the nascent podosome
belt, along with dynamin, supporting a role for cortactin in actin assembly.
INTRODUCTION
Cortactin is a prominent Src substrate (Maa et al., 1992)
expressed in many vertebrate cell types. Hematopoietic cells
generally express the cortactin homologue hematopoietic
cell-specific 1 (HS1) instead of cortactin. In cultured fibro-
blasts, cortactin localizes to sites of dynamic actin assembly,
including lamellipodia (Weed et al., 2000). Biochemical stud-
ies have shown that cortactin can bind Arp2/3 complex and
actin filaments, which enhances Arp2/3-induced nucleation
and stabilizes actin filament branches (Weaver et al., 2001).
Wiskott-Aldrich syndrome protein (WASp) family members
also bind Arp2/3 complex, but they bind actin monomers,
which makes them more efficient at nucleation. Cortactin
and WASp can be synergistic in vitro because they are able
to bind to Arp2/3 complex at the same time (Weaver et al.,
2002).
Cortactin has a Src homology (SH)3 domain and a proline-
rich region, which are not required for F-actin and Arp2/3
interaction (Figure 1A). These regions may allow cortactin to
function as an adaptor to amplify cellular signaling path-
ways. The signaling and actin assembly functions of cortac-
tin may both exist, working in a positive feedback loop.
We chose osteoclasts as a system to study the cellular
function of cortactin for several reasons. First, osteoclasts are
available as primary cells whose physiological function,
namely, resorption of bone, can be assayed directly. Second,
osteoclasts express cortactin, but they are derived from
monocytic precursors that lack cortactin. Finally, cortactin is
a target of c-Src, which is critical for osteoclast function
(Soriano et al., 1991).
In vertebrates, bone remodeling and turnover requires
osteoclasts to resorb bone. Osteoclasts form an integrin-
based contact with the bone surface (Vaananen et al., 2000),
which in association with actin forms a ring-shaped sealing
zone (Kanehisa et al., 1990; Saltel et al., 2004). Osteoclasts
secrete acid and proteases inside the sealing zone, which
degrades the bone.
On nonosteoid surfaces (Saltel et al., 2004), actin in oste-
oclasts forms podosomes, filopodia, and lamellipodia at the
cell edge. Podosomes are small columns of F-actin, surrounded
by a ring of proteins characteristic of integrin-based focal ad-
hesions. Podosomes are also a prominent feature of the actin
cytoskeleton of dendritic cells (Burns et al., 2001), macrophages
(Linder et al., 1999), smooth muscle cells (Gimona et al., 2003),
and Src-transformed fibroblasts (Mizutani et al., 2002). The
F-actin core of podosomes contains the actin nucleator Arp2/3
complex and its activators cortactin, WASp, and neuronal-
WASp (N-WASp) (Linder and Aepfelbacher, 2003). Arp2/3
complex depletion results in fewer podosomes and no seal-
ing zone formation in an osteoclast-like cell line (Hurst et al.,
2004).
In vivo evidence about the importance of cortactin-based
actin assembly in osteoclast function and podosome forma-
tion is lacking. We depleted cortactin in primary mouse
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osteoclasts using short hairpin RNA (shRNA) delivered
with a lentiviral system (Rubinson et al., 2003). We found
that cortactin was absolutely necessary for bone resorption,
sealing zone formation, and podosome formation in oste-
oclasts but that cell differentiation and actin-based motility
were otherwise remarkably normal. In addition, rescue studies
of cortactin knockdown cells with exogenous cortactin and
cortactin mutants suggest a critical role for cortactin’s ty-
rosine phosphorylation downstream of Src.
MATERIALS AND METHODS
Antibodies and Reagents
Antibodies were raised in chickens against a N-terminal fragment of mouse
cortactin (C90) and used for immunoblots. Anti-Arp3 antibody (R43) was
used as described previously (Welch et al., 1997). The 3F2 monoclonal anti-
body (mAb) against capping protein 2 was used for immunoblots as de-
scribed previously (Schafer et al., 1994). The 4F11 mAb against cortactin was
a gift from Dr. Scott Weed (West Virginia University, Health Sciences Center,
Morgantown, WV) and was used in immunofluorescence staining (Kanner et
al., 1990). The monoclonal anti-c-Src antibody was a gift from Dr. Steven
Teitelbaum (Department of Pathology, Washington University School of
Medicine, St. Louis, MO). The monoclonal anti-actin antibody C4 was a gift
from Dr. James Lessard (Department of Pediatrics, University of Cincinnati,
Cincinnati, OH) (Lessard, 1988). Anti-c-Fos, anti-nuclear factor of activated
T-cells c1 (NFATc1), anti-N-WASp, and anti-WASp rabbit polyclonal antibod-
ies and anti-dynamin2 goat polyclonal antibody were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Anti-3 integrin rabbit polyclonal
antibody was purchased from Cell Signaling Technology (Beverly, MA).
Anti-Pyk2 rabbit polyclonal antibody was purchased from BioSource Inter-
national (Camarillo, CA). Anti-FLAG mAb M2 and rhodamine- and couma-
rin-labeled phalloidin were purchased from Sigma-Aldrich (St. Louis, MO).
Horseradish peroxidase (HRP)-conjugated anti-chicken, anti-mouse, and anti-
rabbit second antibodies (Pierce Chemical, Rockford, IL) were used in immu-
noblots. Alexa-conjugated anti-mouse, anti-rabbit, and anti-goat second antibod-
ies (Invitrogen, Carlsbad, CA) were used for immunofluorescence. Glutathione
S-transferase (GST)-receptor activator of nuclear factor B ligand (RANKL) was
purified as described previously (McHugh et al., 2000).
Mouse Osteoclast Culture
Bone marrow macrophages were isolated from 4- to 8-wk-old mice, cultured
overnight in -minimal essential medium (MEM) containing 10% heat-inac-
tivated fetal bovine serum (FBS), and subjected to Ficoll-Hypaque gradient
purification as described previously (Feng et al., 2001). Cells (5  106) col-
lected from the gradient interface were plated in a P100 suspension culture
dish (Corning Costar, New York, NY) in the presence of 1:10 CMG14-12
culture supernatant (Takeshita et al., 2000), containing the equivalent of 120
g/ml recombinant macrophage colony-stimulating factor (MCSF). The cells
were infected with lentivirus at 3 d after harvest. For in vitro generation of
osteoclasts, macrophages were cultured in -MEM containing 10% heat-
inactivated FBS in the presence of 100 ng/ml RANKL and 100 g/ml MCSF
for 5 d. In culture, lentivirus-infected and uninfected osteoclasts were viable
and looked morphologically healthy for at least 10 d in the presence of MCSF
and RANKL. Experiments on glass were performed after 5 d in culture, and
experiments on bone were performed after 8 d in culture.
Reverse Transcription-Polymerase Chain Reaction
(RT-PCR)
Total RNA was collected from macrophages after 0–4 d of RANKL treatment
using the RNeasy kit (QIAGEN, Valencia, CA). Reverse transcription from
equal amounts of total RNA was performed using the SuperScript system
(Invitrogen), followed by PCR with oligonucleotides specific for cortactin,
HS1, WASp, N-WASp, WAVE1, WAVE2, WAVE3, and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH).
Lentivirus and RNA Interference (RNAi)
The pLL3.7 lentiviral-based shRNA expression system (kindly provided by
Dr. Frank Gertler, Massachusetts Institute of Technology, Cambridge, MA)
was used as described previously (Rubinson et al., 2003). Short hairpin RNA
sequences were selected to target the coding region of mouse cortactin.
Sequence 1 and 2 targeted the 5-ggattcggcgggaagtatg-3 coding region and
the 5-gactgagaagcatgcctcc-3 coding region of the cortactin gene, respec-
tively. As a control, we scrambled sequence 1 to give 5-ggacaggtaggttcgtgag-
3, which has no significant similarity to known genes as assessed by National
Center for Biotechnology Information BLASTn searches. 293T cells were
cotransfected with pLL3.7 and packaging plasmids pHR’CVM8.2R and
pCMV-VSV-G (gifts from Dr. Sheila Stewart, Washington University School
of Medicine) using FuGENE (Roche Diagnostics, Indianapolis, IN). Optimal
viral particle numbers for infection were based on infection efficiency, deter-
mined from the percentage of target cells with green fluorescent protein
(GFP), which is expressed independently from the RNAi sequence. Concen-
trated viral titers for multiplicity of infection (MOI) studies were obtained by
centrifugation of viral supernatants at 83,000  g for 90 min. Based on MOI
studies, viral titers of 3  106 viral particles were used for optimal infection.
Figure 1. Expression of cortactin and other Arp2/3 activators dur-
ing osteoclast differentiation. (A) Schematic representation of mouse
cortactin and major interacting partners. Cortactin’s N-terminal
acidic (NTA) domain binds Arp2/3 complex and the repeat region
binds actin filaments. The helical/proline-rich domain contains
three tyrosines (421, 466, and 482) that are targeted for phosphory-
lation by active Src. The SH3 domain of cortactin binds a number of
proline-rich–containing proteins (denoted by X), including
N-WASp and dynamin. (B) Expression of cortactin and other
Arp2/3 complex activator genes by RT-PCR of primary macro-
phages cultured in the presence of RANKL for the indicated num-
ber of days. GAPDH is a control. (C) Anti-cortactin and rhodamine-
phalloidin staining of cells differentiated for 4 d. Cortactin is present
in multinucleated osteoclasts (OC) but not in macrophages (arrow).
An asterisk marks a mononucleate cortactin-positive cell, which is
presumably a maturing osteoclast before fusion.
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To infect macrophages, the virus-containing supernatant was collected 3 d
after transfection of packaging cells and added to bone marrow macrophages
plated on a P100 culture dish along with 8 g/ml protamine sulfate. After 4 h,
the viral supernatant was replaced with fresh macrophage media. Cells were
cultured 2–3 d in macrophage medium, lifted using trypsin/EDTA, and
resuspended in Hank’s balanced salt solution supplemented with 1% FBS for
sorting. Infectivity efficiencies were determined by observing GFP expression
in infected cells as a function of lentiviral titer. Cells from the highest infec-
tivity titer where then sorted for GFP expression using fluorescence-activated
cell sorter (FACS) to enrich for infected cell populations. Cells were sorted for
GFP expression in the Siteman Cancer Center High Speed Sorter Core Facility
using a MoFlo high-speed flow cytometer (Dako Colorado, Fort Collins, CO).
GFP-positive cells were plated on glass or dentine slices in osteoclast differ-
entiation medium.
Retrovirus and Cortactin Mutants
The pBABE murine leukemia virus retroviral-based expression system was
kindly provided by Dr. Sheila Stewart (Washington University School of
Medicine). FLAG-tagged cortactin wild-type and mutant (3YF and W525K)
cDNAs were expanded by PCR from previously described plasmids (Head et
al., 2003; gifts from Dr. Scott Weed, West Virginia University, Health Sciences
Center, Morgantown, WV) and cloned into the pBABE expression plasmid.
RNAi-resistance was conferred by mutating three nucleotides in the region
targeted by RNAi sequence 1 from 5-ggattcggcgggaagtatg-3 to 5-ggcttcg-
gagggaaatatg-3 with the QuikChange multisite-directed mutagenesis kit
(Stratagene, La Jolla, CA). To generate retrovirus, 293T cells were cotrans-
fected with pBABE constructs and packaging plasmids pUMVC3 and pCMV-
VSV-G (gifts from Dr. Sheila Stewart, Washington University School of Med-
icine) using FuGENE (Roche Diagnostics). Viral titers of 3  106 viral
particles were used for optimal infection. This viral titer had no cytotoxic
effects on target cells. The virus-containing supernatant was collected 3 d after
transfection and added to bone marrow macrophages plated on a acid-
washed glass coverslips in culture dishes along with 8 g/ml protamine
sulfate. After 4 h, the viral supernatant was replaced with fresh macrophage
medium. Cells were cultured 2–3 d and then treated with 2 g/ml puromycin
in osteoclast medium containing RANKL, as described above.
Western Blot Analysis
Cells were lysed in SDS sample buffer, boiled, and electrophoresed on 10%
SDS-polyacrylamide gels. Proteins were transferred to polyvinylidene diflu-
oride membranes, which were blocked with 2% bovine serum albumin (BSA)
in phosphate-buffered saline (PBS) containing 0.1% Tween 20. Membranes
were incubated with the appropriate antibody for 1 h in blocking solution,
followed by HRP-conjugated second antibody incubation for 1 h in blocking
solution. Bands were visualized with an ECL kit (GE Healthcare, Little
Chalfont, Buckinghamshire, United Kingdom), followed by exposure to au-
toradiography film.
Immunofluorescence and Time-Lapse Movies
For immunofluorescence, cells on coverslips or dentine were fixed with 2%
paraformaldehyde in PBS at room temperature for 15 min, permeabilized
with 0.5% Triton X-100 in PBS for 1 min, followed by blocking with 8% BSA
in PBS for 1 h. For anti-Arp3 staining, cells were treated with an additional
methanol rinse and costained for actin using monoclonal anti-actin (C4)
antibodies. All other actin staining was done with fluorescent-labeled phal-
loidin. Cells were incubated in primary antibody solutions containing 2% BSA
in PBS for 1 h, followed by Alexa-conjugated second antibody solution
containing 2% BSA in PBS for 1 h. Coverslips were mounted on glass slides,
and dentine slices were mounted on coverslips. Images were collected with an
Olympus IX70 inverted microscope (Olympus, Melville, NY) equipped with a
10 Plan 0.25 Ph1 phase objective, a 100 PlanApo 1.40 oil objective (immu-
nofluorescence microscopy), and a 60 PlanApo 1.40 oil Ph3 phase objective
(immunofluorescence and time-lapse microscopy). Images were captured
with a Coolsnap HQ camera (Photometrics, Tucson, AZ) and processed using
QED In Vivo software (Media Cybernetics, Silver Spring, MD). For time-lapse
movies, cells on glass coverslips were mounted on glass slides and bathed in
10% FBS in DMEM containing 25 mM HEPES buffer without phenol red
(Invitrogen). Images were captured every 10 s for 5 min. The sample
temperature was maintained at 37°C.
Scanning Electron Microscopy (SEM)
Cells on glass coverslips were fixed for 2 h with 2% phosphate-buffered
glutaraldehyde, postfixed with 1% aqueous osmium tetroxide for 1 h, dehy-
drated in an ethyl alcohol series, and critical point dried from liquid CO2.
Mounted coverslips were sputter-coated with 30 nm of gold and examined by
Dr. Michael Veith (Washington University, St. Louis, MO) in a Hitachi S-450
scanning electron microscope (Hitachi America, Brisbane, CA) at 20-KV ac-
celerating voltage.
Tartrate-resistant Acid Phosphatase (TRAP) Staining and
Bone Resorption
Bone resorption was assayed by culturing macrophages on dentine slices in
the presence of RANKL and MCSF for 8 d. Cells were fixed with 2% para-
formaldehyde in PBS and stained for TRAP to confirm osteoclastogenesis
using a kit (Sigma-Aldrich, St. Louis, MO). For resorption pit visualization,
cells were removed by brief treatment with 2 N NaOH followed by 0.5%
toluidine blue solution staining.
RESULTS
Cortactin Is Expressed during Osteoclast Differentiation
Cortactin is expressed in all vertebrate cells and tissues,
except in cells of hematopoietic origin, which generally ex-
press only the cortactin homologue HS1 (Kitamura et al.,
1995). Because osteoclasts are hematopoietic-derived cells
and are known to express cortactin (Hiura et al., 1995), we
asked whether cortactin would be expressed during differ-
entiation of osteoclasts in culture, from monocyte precur-
sors. RT-PCR was performed on primary bone marrow mac-
rophages induced to differentiate into osteoclasts with
RANKL and MCSF (Yasuda et al., 1998). After 5 d, 90% of
macrophages differentiated into osteoclasts. Cortactin was
undetectable initially, and expression was induced during
differentiation (Figure 1B). Immunofluorescence staining
confirmed that osteoclasts and their mononuclear precursors
express cortactin, whereas the few macrophages that did not
differentiate were negative for cortactin (Figure 1C). HS1
was expressed, at a constant level, during the time course of
differentiation (Figure 1B).
In vitro, cortactin activates Arp2/3 complex in a manner
synergistic with WASp family members (Weaver et al.,
2002). We asked whether the expression of any other Arp2/3
activators changed during osteoclast differentiation. The lev-
els of WASp, N-WASp, and WAVE2, assessed by RT-PCR,
did not change during osteoclast differentiation (Figure 1B).
WAVE1 expression was low, detected only with additional
PCR cycles, and its level did not change (our unpublished
data). WAVE3 expression was not detected, even with ad-
ditional cycles.
Cortactin Depletion in Osteoclasts Using Lentiviral RNAi
Expression
To determine the role of cortactin in actin assembly and the
function of osteoclasts, we depleted cortactin using RNAi. A
lentiviral system was used. Lentiviruses integrate into the
host cell genome, so the cells maintained a constitutive
expression of RNAi after infection. The lentiviral vector
expressed GFP as an independent marker, allowing us to
sort and collect a homogenous population of infected pri-
mary macrophages, which we then induced to differentiate
into osteoclasts.
First, we assessed the efficiency of the infection and the
health of the cells as a function of viral titer. To assess
infection efficiencies, the percentage of cells expressing GFP
was measured by FACS, as a function of viral titer (Figure
2A). The highest infectivity rates were achieved with 3 106
viral particles for control and knockdown lentivirus, with
lower infectivity rates at lower and higher viral titers. This
optimal viral titer was used for most subsequent experi-
ments, followed by sorting of GFP-positive cells to enrich for
infected cells. To test for adverse effects of viral infection on
the cells, we assessed the viability of macrophages, as a
function of viral titer. Cells were infected, sorted by FACS,
and plated on glass. The number of cells that were alive and
adherent was followed by phase-contrast microscopy for 2–5
d, which is the number of days required for in vitro differ-
S. Tehrani et al.
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entiation of macrophages into osteoclasts. Control and
knockdown infected macrophages remained fully viable
and adherent over time regardless of the viral titer used for
infection (Figure 2B).
We assessed the efficiency of cortactin knockdown with
immunoblots and immunofluorescence. Two different RNAi
sequences targeting cortactin (1 and 2) and a scrambled
RNAi control sequence were used. The level of cortactin
knockdown with RNAi sequence 1 or 2 in osteoclasts was
90% by immunoblot analysis (Figure 2C). Cortactin immu-
nofluorescence staining was diminished to background lev-
els in cells expressing RNAi sequence 1 or 2, with no change
in cells expressing control RNAi (Figure 2D).
Cortactin-depleted Osteoclasts Fail to Form Sealing Rings
and Resorb Bone
We assessed the ability of cortactin-depleted osteoclasts to
resorb bone. Macrophages expressing RNAi were plated on
dentine and differentiated into osteoclasts. The number of
mature osteoclasts on dentine was the same for cortactin-
depleted and control cells, revealed by counting cells (Figure
3A) and staining for TRAP, an osteoclast marker (Figure 3B).
Large, multinucleated cells were observed in control and
knockdown cells, indicating normal fusion during differen-
tiation (Figure 3B). Osteoclasts expressing scrambled RNAi
produced numerous bone resorption pits, assessed by tolu-
idine blue staining (Figure 3C). In contrast, cells expressing
cortactin RNAi did not produce any resorption pits at all.
Cortactin RNAi sequence 1 and 2 gave the same result.
Control cells expressing scrambled RNAi formed normal
sealing rings that contained F-actin and cortactin (Figure
3D). Cells depleted for cortactin did not form actin-rich
sealing rings. Their morphology resembled that of macro-
phages, as assessed by rhodamine-phalloidin (Figure 3D).
The Role of Cortactin in Osteoclast Actin Assembly on
Nonosteoid Surfaces
On glass and other nonosteoid surfaces, the most prominent
feature of the actin cytoskeleton of osteoclasts is a belt of
podosomes just behind the cell edge, with lamellipodia and
filopodia at the cell edge. Podosomes have a central core of
F-actin and actin-binding proteins, surrounded by a ring of
proteins found in focal adhesions (Linder and Aepfelbacher,
2003). We observed cortactin staining in podosomes in all
Figure 2. Knockdown of cortactin in osteoclasts. (A) Infectivity rate, based on GFP expression, as a function of viral titer. Macrophages were
infected with lentivirus expressing a cortactin RNAi knockdown sequence (1) or a control scrambled RNAi sequence. The RNAi plasmid
expressed GFP independently. (B) FACS-sorted macrophages were cultured on glass in osteoclast medium. Viability was assessed by
phase-contrast morphology and by substrate attachment. (C) Level of cortactin in knockdown cells, by immunoblot. Infected and FACS-
sorted macrophages were differentiated into osteoclasts for 5 d in culture. The samples are the control scrambled RNAi sequence, the cortactin
knockdown RNAi sequence 1, and the cortactin knockdown RNAi sequence 2. Capping protein 2 is a loading control. (D) Anti-cortactin
immunofluorescence of cortactin in osteoclasts expressing control RNAi or knockdown RNAi sequence 1, plated on glass. The level of
fluorescence in the knockdown cells was similar to that seen for controls without first antibody. GFP accumulates in the nuclei of infected
cells.
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mature osteoclasts (Figure 4A), along with F-actin and
Arp2/3 complex, assessed by rhodamine-phalloidin and
anti-Arp3 staining, respectively (Figure 4, A and B).
Depletion of cortactin caused an essentially complete loss
of podosomes, as revealed by rhodamine-phalloidin fluores-
cence and phase-contrast microscopy (Figure 5A). The area
where podosomes were lost showed weak diffuse F-actin
staining, when the gain was increased, and the phase-con-
trast image had a ground-glass appearance. These features
are consistent with the presence of an actin filament network
that excludes vesicles. This phenotype was rescued by ex-
pression of RNAi-resistant wild-type cortactin expression, as
described below, which confirms the specificity of the
knockdown effects.
We asked whether cortactin-depleted cells had short-lived
podosomes by performing time-lapse phase-contrast movies
(Supplemental Movies 1 and 2). In control cells, podosomes
looked like a belt of phase-dark puncta a short distance from
Figure 3. Cortactin-depleted osteoclasts are
viable and differentiate on bone, but they fail
to resorb bone or form sealing rings. (A) Cell
viability. Macrophages expressing scrambled
or cortactin RNAi sequence 1 were plated on
dentine slices and differentiated into oste-
oclasts for 8 d. Cells were counted on day 1
and day 8. (B) Osteoclast differentiation. Cells
on dentine as in A were stained for an oste-
oclast-specific marker, TRAP. RNAi control
and knockdown sequence 1 samples are
shown. The number of cells and the degree of
TRAP staining is similar. (C) Bone resorption.
After removal of osteoclasts, dentine slices
were stained with toluidine blue solution to
reveal resorption pits. Pits seem dark by trans-
mitted light microscopy. Control cells pro-
duced pits, and knockdown cells showed no
evidence of resorption. (D) Actin sealing ring
formation. Osteoclasts on dentine were
stained with rhodamine-phalloidin and anti-
cortactin antibody. Control osteoclasts formed
actin rings, and knockdown cells did not. Rep-
resentative examples are shown.
Figure 4. Cortactin, actin, and Arp2/3 com-
plex localization to podosomes. Osteoclasts on
glass were costained for cortactin and F-actin,
or Arp3 and actin. (A) Low- and high-magni-
fication fluorescence images of osteoclasts
stainedwithanti-cortactinantibodyandrhoda-
mine-phalloidin. (B) Higher magnification im-
ages of the periphery of two adjacent oste-
oclasts stained with anti-Arp3 and anti-actin
antibodies. In all images, podosomes look like
punctate, fluorescent structures. Diffuse stain-
ing for actin, cortactin, and Arp3 is observed
between podosomes.
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the cell edge. Characteristic of podosomes, the puncta ap-
peared and disappeared on a time scale of minutes, and they
did not move relative to the substrate (Supplemental Movie
1). Cortactin-depleted cells had no podosomes, and the area
had a ground-glass appearance (Figure 5A and Supplemen-
tal Movie 2, respectively).
We asked how well the presence of cortactin correlated
with the presence of podosomes, by infecting cells with
different amounts of virus. As the viral titer increased, the
percentage of cells displaying cortactin staining decreased.
The percentage of cells with podosomes also decreased in a
similar manner, indicating a correlation between the pres-
ence of cortactin and podosomes (Figure 5, B and C).
We asked whether other aspects of actin-based motility
were affected by cortactin depletion. Lamellipodial and
filopodial structures were seen at the cell edge of cortactin-
depleted cells by rhodamine-phalloidin staining and phase-
contrast imaging of fixed preparations (Figure 5A) and by
time-lapse phase-contrast imaging of live cells (Supplemen-
tal Movies 1 and 2 and Figure 6A). Compared with control
Figure 5. Cortactin depletion results in loss of podosomes in osteoclasts. (A) Fluorescence and phase-contrast images of osteoclasts stained
with anti-cortactin antibodies and rhodamine-phalloidin after infection with lentivirus expressing a control scrambled RNAi (top) or cortactin
RNAi sequence 1 or 2 (middle and bottom, respectively). The level of fluorescence in the anti-cortactin images of cells depleted for cortactin
was the same as that seen in cells stained with second antibody alone (our unpublished data). The F-actin images on the left were captured
at a gain setting optimal for observing podosomes. The F-actin images on the right are high magnifications of the boxed areas, collected with
a higher gain setting, which reveals that the knockdown cells have a persisting presence of F-actin in the region that would be occupied by
podosomes, along with lamellipodia- and filopodia-like structures at the cell edge. (B) The percentage of cells displaying immunofluorescence
staining for cortactin as a function of lentiviral titer for control and knockdown cell samples. Samples were assessed visually using
fluorescence microscopy. Cells displaying any detectable cortactin staining above background were included as positive. (C) The percentage
of cells displaying podosomes as a function of lentiviral titer for control and knockdown cell samples. Samples were assessed visually using
rhodamine-phalloidin staining and fluorescence microscopy. Cells displaying any number of podosomes were included as positive, as
assessed by rhodamine-phalloidin staining.
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cells, cortactin-depleted cells showed a slight increase in the
ratio of lamellipodia to filopodia in the phase-contrast mov-
ies. The movies also revealed phase-light and phase-dark
vesicles undergoing rapid saltatory motion in a region just
behind the podosome area, with no obvious effect from
cortactin depletion (Figure 6A). The overall shape and size
of the osteoclasts on glass were not changed by cortactin
depletion, based on phase-contrast light microscopy and
SEM images. SEM showed filopodia-like structures and
membrane protrusions on the dorsal surface of knockdown
and control cells (Figure 6B). Overall, control and knock-
down cells were relatively similar in these other manifesta-
tions of actin assembly and actin-based motility.
We asked whether RANKL-induced osteoclast differenti-
ation occurred normally in cells depleted for cortactin.
RANKL signaling results in the expression of a number of
osteoclast-specific proteins. Control and cortactin-depleted
cells expressed c-Fos, c-Src, NFATc1 and -3 integrin upon
RANKL treatment, all of which are markers of osteoclast
maturation not found in macrophages (Figure 6C). Cell fu-
sion also occurred, which is characteristic of osteoclast dif-
ferentiation, with no apparent difference in the average
number of nuclei per cell between control and knockdown
cells (Figure 2D; our unpublished data).
Cortactin Is an Early Component for Podosome Belt
Formation
To understand how cortactin depletion affects podosome
dynamics, we examined the assembly and disassembly of
podosomes. When a cell edge was advancing, a single belt of
podosomes was generally observed, in the area just behind
the cell edge (Supplemental Movie 1). The belt was several
podosomes wide. New podosomes formed at the peripheral,
outer, edge of the belt, whereas podosomes disappeared
from the central, inner, edge of the belt. The lifetime of a
podosome was 2 min. These findings are consistent with
previous studies (Destaing et al., 2003).
In contrast, when a cell was stationary, we often observed
two belts of podosomes separated by 1–2 m (Figure 7A and
Supplemental Movie 3). Alone, each belt resembled a single
belt described above, in terms of the number, arrangement,
and behavior of the individual podosomes. Each belt moved
outward, in the manner of single belts. The key difference
was in their life cycle. At some point in time, the outer belt
disappeared, because all its podosomes disassembled, and a
new inner belt appeared, with podosomes assembling de
novo. The inner belt would move out, and then the cycle
would repeat. Thus, when two belts of podosomes were
present, the inner belt was newer than the outer one, in
every case.
In fixed cell preparations, costained for cortactin and F-
actin, the inner, newer belt had less intense rhodamine-
phalloidin staining than did the outer belt, and this differ-
ence was reflected in the darkness of the podosomes in the
phase-contrast images (Figure 7A). In contrast, cortactin
stained both belts equally well, suggesting that cortactin
occurs early in the life of a podosome belt.
We asked whether a similar trend in cortactin:F-actin ratio
could be observed by comparing individual podosomes
within a single belt. In this case, new podosomes are those
on the outer edge of the belt. We measured the fluorescence
intensities of cortactin and F-actin for individual podosomes
in double-stained images (Figure 7B). We calculated the
ratio of cortactin:F-actin fluorescence for each podosome,
measured its distance from the cell edge and plotted the
average ratio versus the distance (Figure 7, C and D). Over-
all, the curves showed no consistent trend up or down, even
Figure 6. Effect of cortactin depletion on podosomes, membrane
protrusions, and osteoclast maturation. (A) Membrane and cell edge
dynamics in time-lapse phase-contrast microscopy movies of osteoclasts
expressing scrambled or cortactin RNAi sequence 2. These images are
frames from Supplemental Movies 1 and 2. Podosomes are seen as phase-
dark puncta just behind the cell edge in control cells. Cortactin-depleted
cells show no podosomes. Control and cortactin-depleted cells exhibit
dynamic membrane protrusions, including lamellipodia (white arrows).
Rapidly moving phase-light and phase-dark vesicles are seen farther back
from the cell edge in control and knockdown cells (black arrowheads).
These vesicles may be endocytic. (B) Scanning electron microscopy of
osteoclasts expressing scrambled or cortactin RNAi sequence 1. Control
and cortactin-depleted cells show filopodia-like structures and dorsal
membrane protrusions. (C) Immunoblot of osteoclast markers in cells
expressing control scrambled RNAi, knockdown sequences 1 or knock-
down sequence 2. Pyk2 is a loading control. All four osteoclast markers
tested are present in control and cortactin-depleted cell samples.
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when the curves were aligned at the starting point (Figure
7D). That a difference is seen when comparing two belts, and
not podosomes within one belt, may reflect the spatial reg-
ulation of the assembly process or the magnitude of the
temporal differences in age.
Because cortactin localized to nascent podosome belts and
cortactin depletion resulted in the loss of podosomes, we
asked whether other podosome components were able to
localize in a podosome-like pattern despite the absence of
cortactin and F-actin. Dynamin2 has been found in podo-
somes of osteoclasts and RSV-transformed cells (Ochoa et al.,
2000), and the SH3 domain of cortactin can bind directly to
the proline-rich region of dynamin (Weed and Parsons,
2001). N-WASp localizes to podosomes of Src-transformed
fibroblasts (Mizutani et al., 2002), and cortactin can bind and
activate N-WASp in vitro (Kowalski et al., 2005). WASp is
important for podosome formation in macrophages (Linder
et al., 1999) and osteoclasts (Calle et al., 2004). Here, dy-
namin2, N-WASp and WASp localized in a punctate pattern
with podosomes in control osteoclasts (Figure 8). Dynamin2
showed preferential staining of the inner podosome belt,
when two belts were present (Figure 8A). On cortactin de-
pletion, the distribution of all three proteins was diffuse in
the cytoplasm, without any appreciable punctate podosome
pattern (Figure 8, A–C). Thus, assembly of dynamin, N-
WASp, and WASp at the podosome either depends on or,
more likely, is cooperative with that of cortactin and F-actin.
Expression of Cortactin Mutants in Control and
Knockdown Cells
To investigate the biochemical basis of cortactin’s function in
osteoclasts, we expressed cortactin mutants using an N-
terminal FLAG tag and a retroviral system (Figure 9A). The
3YF mutant of cortactin contained 3 tyrosine-to-phenylala-
nine mutations at residues Y421, Y466, and Y482, which are
known to be phosphorylated downstream of Src in cells and
to account for essentially all of the Src-induced tyrosine phos-
phorylation of cortactin in cells (Head et al., 2003). The SH3
mutant of cortactin contained a tryptophan-to-lysine mutation
at W525, which causes loss of binding to proline-rich ligands
(Kinley et al., 2003).
First, we expressed the cortactin mutants in osteoclasts
that had normal levels of endogenous cortactin. The level of
exogenously expressed FLAG-tagged cortactin was two- to
threefold higher than that of endogenous cortactin, based on
anti-cortactin immunoblots (Figure 9B). The SH3 point mu-
Figure 7. Cortactin and F-actin in podosome belt mat-
uration. (A) An example of anti-cortactin and F-actin
(rhodamine-phalloidin) staining of a cell region with
two podosome belts. Cortactin fluorescence intensity is
similar in the two belts, whereas the F-actin fluores-
cence and phase-contrast darkness are more pro-
nounced in the outer belt (black arrow) than in the inner
belt (white arrow). (B) Podosome belt formation in
time-lapse phase-contrast microscopy. Images are
frames from Supplemental Movie 3. These movies re-
veal that the outer belt (black arrow) is older, and the
inner belt (white arrow) is younger. (C) Quantitation of
anti-cortactin and F-actin (rhodamine-phalloidin) fluo-
rescence of individual podosomes within a single belt.
Boxes were placed around podosomes, and pixel fluo-
rescence values were determined. Boxes 1–4 are exam-
ples of podosomes 0.1, 5, 10, and 15 m from the cell
edge (arrow). (D) Fluorescence intensities for multiple
podosomes within a single belt were averaged and
plotted as a function of distance from the cell edge. Each
plot of the 12 curves represents the averaged podosome
intensity ratios from a single osteoclast. The graph on
the left plots the actual ratios. For the graph on the
right, the curves were adjusted up or down to begin at
the same point.
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tant of cortactin migrated slower than wild-type cortactin in
the SDS gel, as seen previously (Kowalski et al., 2005).
Overexpression of wild-type cortactin in osteoclasts did
not significantly alter the percentage of cells containing po-
dosomes, and the cells looked normal by phase-contrast
microscopy and phalloidin staining (Figure 9, C and D).
Expression of either the SH3 mutant or the 3YF mutant of
cortactin resulted in an 20–30% statistically significant
decrease in the number of osteoclasts with podosomes (Fig-
ure 9C). In cells with podosomes, the FLAG-tagged SH3 and
3YF mutant cortactins localized normally to podosomes, as
did FLAG-tagged wild-type cortactin (Figure 9D). Biochem-
ically, cortactin is a monomer (Weaver et al., 2002), so the
ability of the FLAG-tagged mutants to localize normally is
probably not due to association with endogenous wild-type
cortactin. Thus, the SH3 and 3YF cortactin mutants caused
small but statistically significant dominant negative effects
on podosome assembly.
Next, we tested the ability of the mutants to rescue podo-
some assembly in cells depleted of cortactin by knockdown.
These FLAG-tagged cortactin rescue expression constructs
were rendered resistant to the cortactin RNAi knockdown
sequence 1 by three codon-neutral nucleotide changes. Ex-
pressed in 293T cells, the protein levels for the mutants and
wild-type cortactin rescue constructs were similar to each
other and near that of endogenous cortactin, based on anti-
cortactin immunoblots (Figure 10A). Primary macrophages
were infected with control and cortactin knockdown lenti-
virus and sorted for GFP expression as described above.
Those cells were then infected with retroviral cortactin ex-
pression constructs. The retroviral constructs contained a
puromycin resistance marker, which allowed us to select for
Figure 8. Localization of dynamin2, N-WASp, and
WASp in control and cortactin-depleted osteoclasts. (A)
Dynamin2 localized predominantly to the inner podo-
some belt in osteoclasts expressing control scrambled
RNAi. Dynamin2 was not observed at the cell edge in
cells expressing cortactin RNAi sequence 1. N-WASp
(B) and WASp (C) localized equally well to the inner
and outer podosome belts in control osteoclasts ex-
pressing scrambled RNAi. This localization was lost,
and the staining was diffuse after cortactin depletion
(cortactin RNAi sequence 2 in B and cortactin RNAi
sequence 1 in C). Black arrows point to the older outer
belts, and white arrows point to the new inner belts.
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infected cells. Puromycin-resistant cells were differentiated
into osteoclasts, and the presence of podosomes was as-
sessed.
In cells expressing control scrambled RNAi, the 3YF and
SH3 cortactin mutants had small dominant negative effects
(Figure 10B, left) similar to those described above for cells
without RNAi (Figure 9C). Cortactin knockdown cells in-
fected with an empty rescue expression construct had a
greatly decreased percentage of osteoclasts with podosomes,
as expected, and expression of wild-type cortactin restored
Figure 9. Effects of overexpression of cortactin mutants on podosome formation. (A) Diagram illustrating the nature of the cortactin
mutants. All constructs included an N-terminal FLAG tag. 3YF contains three tyrosine to phenylalanine mutations (residues 421, 466, and
482), and SH3† contains the mutation W525K in the SH3 domain. (B) Anti-cortactin immunoblot of osteoclasts expressing the cortactin
mutants. The FLAG-tagged cortactins run higher than endogenous cortactin, and the SH3 W525K mutant is anomalously high in SDS gels,
as seen in previous studies. Capping protein 2 is a loading control. (C) Percentage of osteoclasts with podosomes. Osteoclasts expressing
the cortactin mutant rescue constructs were fixed, stained with rhodamine-phalloidin and viewed by fluorescence microscopy to visualize
podosomes. Error bars are SE of proportion, and asterisks indicate statistical difference (p  0.01) compared with vector and wild type.
Statistical significance was determined by the binomial probability distribution function. The number of cells was 35 in each sample. (D)
Osteoclasts expressing cortactin mutants were fixed and costained with rhodamine-phalloidin and anti-FLAG.
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that value to near normal levels (Figure 10B, right). The
rescued cells appeared normal in phase-contrast and rhoda-
mine-phalloidin fluorescence images (Figure 10C). That
wild-type cortactin rescues confirms that the cortactin
knockdown phenotype is not a nonspecific effect of the
RNAi sequence.
Figure 10. Rescue of cortactin knockdown phenotype
with cortactin mutants. (A) Expression of RNAi-resis-
tant FLAG-tagged cortactin constructs in 293T cells ex-
pressing knockdown or control RNAi. Anti-cortactin
antibody was used, revealing absence of cortactin in
cells expressing knockdown RNAi, and restoration of
cortactin in knockdown cells expressing FLAG-tagged
wild-type and mutant cortactin constructs. (B) Presence
of podosomes in cells expressing rescue constructs.
Cells expressing control scrambled RNAi (left) or cor-
tactin knockdown RNAi sequence 1 (right) were in-
fected with RNAi-resistant, FLAG-tagged cortactin res-
cue constructs. The percentage of cells with podosomes
is plotted, based on rhodamine-phalloidin staining of
the differentiated osteoclasts. Error bars are SE of pro-
portion, and asterisks indicate statistical difference (p 
0.01) compared with vector and wild type. Statistical
significance was determined by the binomial probabil-
ity distribution function. (C) Fluorescence and phase-
contrast images of osteoclasts expressing RNAi and
cortactin mutants, fixed, and stained with rhodamine-
phalloidin and anti-FLAG. The top half is cells express-
ing control scrambled RNAi, and the bottom half is cells
expressing cortactin knockdown RNAi sequence 1.
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In contrast, the 3YF cortactin mutant did not rescue the
cortactin knockdown phenotype, producing results similar
to those for empty vector (Figure 10B, right). The SH3 mu-
tant of cortactin was able to rescue, at a level less than but
not significantly different from that of wild type (Figure 10B,
right). We asked how the mutant cortactins localized, by
anti-FLAG staining. In cells expressing control scrambled
RNAi, the cortactin mutants localized to podosomes (Figure
10C), as seen for cells not expressing RNAi (Figure 9D). In
cortactin knockdown cells, 3YF-cortactin was localized dif-
fusely, whereas wild-type and SH3 mutant cortactin local-
ized to podosomes (Figure 10C).
DISCUSSION
We discovered that cortactin is necessary in osteoclasts for
actin ring assembly, bone resorption, and podosome assem-
bly. The knockdown phenotypes were specific, strong, and
highly penetrant. A great deal is known about cortactin’s
biochemical properties to promote actin assembly via
Arp2/3 complex and to act as a scaffold for signaling mol-
ecules in vitro (Weed et al., 2000; Weaver et al., 2001, 2002).
However, the function of cortactin in cells has remained
somewhat elusive. The only study of loss of cortactin func-
tion in an intact organism is in Drosophila, where complete
loss-of-function mutations of the sole cortactin gene had only
minor effects, producing smaller F-actin ring canals of germline
cells and impaired migration of border cells in oogenesis
(Somogyi and Rorth, 2004). In cultured cells, a variety of stud-
ies point to a role for cortactin in actin-based processes such as
pathogen invasion (Lambotin et al., 2005; Selbach and Backert,
2005), endocytosis (Merrifield et al., 2005; Sauvonnet et al.,
2005), post-Golgi transport (Cao et al., 2005), cell adhesion (El
Sayegh et al., 2004; Helwani et al., 2004), and lamellipodial
persistence (Bryce et al., 2005). In these studies, cortactin was
generally found to associate with sites of actin assembly,
and, in some cases, expression of cortactin mutants or
knockdown of cortactin produced partial loss of actin-based
motility or actin cytoskeleton assembly.
We hypothesized that cortactin might have a more crucial
role in osteoclasts because cortactin is expressed in oste-
oclasts (Hiura et al., 1995), and osteoclasts are derived from
hematopoietic cell precursors that express the cortactin ho-
mologue HS1 but not cortactin itself (Miglarese et al., 1994).
Here, we found that cortactin expression was indeed in-
duced upon osteoclast differentiation. In contrast, the ex-
pression of HS1 and other Arp2/3 activators, including
WASp-family members, did not change with osteoclast dif-
ferentiation.
To test our hypothesis, we depleted cortactin from oste-
oclasts using RNAi delivered with lentivirus. Cortactin-de-
pleted osteoclasts plated on bone did not form actin-based
sealing rings and were completely deficient in bone resorp-
tion. We suspect that the actin sealing ring defect is the cause
of the failure in bone resorption, but we cannot rule out the
possibility that secretion of acid and proteases may have
been decreased. On nonosteoid surfaces, osteoclasts form
actin-based podosomes, and we found that cortactin deple-
tion led to the absence of podosomes, based on rhodamine-
phalloidin staining of fixed cells and phase-contrast imaging
of live cells. Thus, cortactin is necessary for podosome as-
sembly in this setting. Recently, cortactin expression was
also shown to be necessary for the podosome formation that
results from phorbol ester treatment of the A7r5 line of
vascular smooth muscle cells (Zhou et al., 2006).
Whether the mechanisms for actin assembly in sealing
rings and podosomes are similar is an open question in
osteoclast biology. Early studies suggested the hypothesis
that podosomes might represent precursors of sealing rings,
based on the localization of podosome-like structures around
resorption pits in fixed cells and on certain similarities in
molecular composition (Kanehisa et al., 1990; Lakkakorpi
and Vaananen, 1991). In contrast, in a recent study of living
osteoclasts on mineralized substratum, actin sealing rings
were observed by GFP-actin imaging, but podosomes were
not seen (Saltel et al., 2004). Inhibition of Rho did convert the
sealing ring into a belt of podosomes (Saltel et al., 2004),
suggesting that podosomes might be rapidly and efficiently
incorporated into the sealing ring by the action of Rho. Our
results here show that the sealing ring and podosomes both
require cortactin to form, providing further evidence for
their relationship.
Perhaps the most remarkable finding from our study was
the specificity of the actin assembly defect caused by the loss
of cortactin in osteoclasts on glass. The cell edge was highly
dynamic in cortactin-depleted cells, in phase-contrast mov-
ies. Lamellipodia and filopodia were both present and dy-
namic. The cortactin-depleted cells showed a slight increase
in the amount of lamellipodial activity, relative to filopodia.
In a detailed study of lamellipodia in the HT1080 fibrosar-
coma cell line, cortactin depletion decreased the persistence
time of lamellipodia by half, with no effect on protrusion
speed, protrusion distance, or retraction speed (Bryce et al.,
2005). Given the proximity of podosomes and lamellipodia
at the cell edge of the osteoclast, and that both seem to be
nucleated by Arp2/3 complex, we find it remarkable that
podosomes are completely absent, whereas lamellipodia are
relatively normal. Therefore, different regulators of Arp2/3
complex may have distinct functions at close locations
within one cell.
A priori, cortactin might promote podosome actin assem-
bly either by increasing actin filament polymerization or by
decreasing depolymerization. In vitro, cortactin activates
Arp2/3 complex for actin nucleation, which increases the
rate of polymerization, but cortactin also stabilizes actin
filament branches formed by Arp2/3 complex, which de-
creases the rate of depolymerization (Weaver et al., 2001).
Cortactin appears before filamentous actin when podosomes
assemble in phorbol ester-stimulated A7r5 smooth muscle
cells (Webb et al., 2006), suggesting that cortactin promotes
actin polymerization. Two results from our study also sup-
port this idea. First, in time-lapse movies of cortactin-de-
pleted cells, podosomes were not observed. If the primary
role of cortactin was to stabilize actin filaments in podo-
somes, then one might have expected to see podosomes
form at normal rates but disassemble rapidly. Second, in
cases where cells had two belts of podosomes at their pe-
riphery, cortactin accumulation seemed to precede that of
F-actin, based on differential staining of the newer, inner
belt. In contrast, when we compared old and new podo-
somes within one belt, in cases where cells only had one belt,
the ratio of cortactin to F-actin was the same. Perhaps the
age differences between old and new podosomes are greater
when a second belt is created.
A number of other molecular components, in addition to
cortactin, are known to play important roles in the assembly
of podosomes and the function of osteoclasts (reviewed by
Linder and Aepfelbacher, 2003). Integrins, signaling pro-
teins, and actin cytoskeleton components have all been im-
plicated in various studies. For example, gelsolin is an actin
filament severing protein found in the podosome, and oste-
oclasts from gelsolin-deficient mice have no podosomes
(Chellaiah et al., 2000). In addition, WASp knockout mice
have moderate deficits in the number of podosome-forming
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osteoclasts (Calle et al., 2004). In this study, WASp-deficient
osteoclasts on bone showed a decrease in the area of bone
surface resorbed, whereas other parameters, such as volume
and depth of resorption pits, were unaffected. In addition,
calpain, which can proteolyze the podosome proteins talin,
Pyk2 and filamin, has been found to be important for oste-
oclast activity (Marzia et al., 2006).
Dynamin localizes to osteoclast podosomes, and expres-
sion of dynamin mutants can inhibit osteoclast activity
(Bruzzaniti et al., 2005). In vitro, dynamin and cortactin can
bind directly to each other, and their interaction can cause
actin assembly on lipid vesicles, in the presence of Arp2/3
(Schafer et al., 2002). Here, we observed dynamin staining of
podosomes, with increased staining of the inner younger
belt, when cells had two belts, consistent with dynamin
being important for podosome assembly.
Dynamin binds to the SH3 domain of cortactin (Schafer et
al., 2002), as do several other proteins, including N-WASp
(Kowalski et al., 2005), faciogenital dysplasia (Kim et al.,
2004), WASp-interacting protein (Kinley et al., 2003), and
CD2AP/CIN85 (Lynch et al., 2003). In osteoclasts, the phys-
iologically relevant binding partners of cortactin’s SH3 do-
main have yet to be defined. Overexpression of a C-terminal
fragment of cortactin, which included the SH3 domain, in-
hibited podosome formation in smooth muscle cells (Webb
et al., 2006), presumably by causing nonproductive interac-
tions with cortactin binding partners. Here, we tested an
SH3 point mutation (W525K) in full-length cortactin for the
ability to rescue the osteoclast knockdown phenotype. The
mutant was able to rescue, at a value less than, but not signif-
icantly different from, that of wild-type cortactin. When ex-
pressed in control cells with normal levels of endogenous
cortactin, this SH3 mutant of cortactin had a modest domi-
nant negative effect. Therefore, the SH3 domain may have a
minor role in cortactin function. The cortactin SH3 mutant
localized to podosomes, so the SH3 domain does not target
cortactin to podosomes. Instead, the SH3 domain may re-
cruit other proteins. This is consistent with studies in fibro-
blasts, in which the N-terminal acidic Arp2/3-binding do-
main and the F-actin binding domain of cortactin are each
necessary and together sufficient for cortactin localization to
lamellipodia (Weed et al., 2000).
The role of cortactin’s tyrosine phosphorylation, down-
stream of Src, has been an important question. Here, we
found that the three tyrosines targeted for phosphorylation
by Src are necessary for podosome formation in osteoclasts,
based on failure of a 3YF mutant to suppress the knockdown
phenotypes. When expressed in cells with endogenous cor-
tactin, this mutant had only a small dominant negative
effect, and the mutant protein localized to podosomes, sug-
gesting that the tyrosine residues have a primary or direct
role in cortactin function. Consistent with our results, the
3YF cortactin mutant failed to rescue a cortactin knockdown
defect in endothelial cells assayed for the ability to support
leukocyte transmigration (Yang et al., 2006).
In conclusion, cortactin-depleted osteoclasts fail to form
actin-based sealing rings and fail to resorb bone, showing
that cortactin-based actin assembly is necessary for the seal-
ing ring to function. On glass, actin-based podosomes do not
form, which supports the notion that podosomes and seal-
ing rings have molecular mechanisms in common. In other
respects, cortactin-depleted osteoclasts are remarkably nor-
mal in terms of actin assembly at the cell edge. A 3YF mutant
of cortactin localizes normally but fails to restore podosome
formation in cortactin-depleted cells, demonstrating the im-
portance of cortactin’s tyrosine phosphorylation down-
stream of Src. In contrast, the SH3 domain of cortactin is
largely dispensable in this context.
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